Rosuvastatin: a highly efficacious statin for the treatment of dyslipidaemia

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.11, Iss.1, 2002-01, pp. : 125-141

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dyslipidaemia in diabetes: combination statin treatment an option

Inpharma, Vol. 1, Iss. 1310, 2001-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Effectiveness and Safety of Ezetimibe Added to Statin Therapy in Patients with Primary Dyslipidaemia not Achieving the LDL-C Treatment Goal on Statin Monotherapy

By González Carlos A. Rubio-Guerra Alberto F. Pavía Abel Redding Francisco J. Cervantes José L. Zacarías José L. Yza Rubén Carranza Jaime Fernández Pedro Morales Enrique Robles Francisco J. Leyva José L. Rodríguez Leticia

Clinical Drug Investigation, Vol. 27, Iss. 5, 2007-01 ,pp. : 333-337

Adis International

Access to resources Recommend Favorite

Rosuvastatin best cost option for dyslipidaemia in Mexico

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 602, 2010-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Dyslipidaemia treatment guidelines `are outdated'

Inpharma, Vol. 1, Iss. 1246, 2000-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Recent developments in the treatment of dyslipidaemia

By Chang G. Ruggeri R.B.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 5, 1997-05 ,pp. : 441-455

Informa Healthcare

Access to resources Recommend Favorite